TITLE

GILENYA for relapsing forms of multiple sclerosis (MS). Discover your POSSIBILITIES

PUB. DATE
October 2012
SOURCE
Momentum (19403410);Fall2012, Vol. 5 Issue 4, p28
SOURCE TYPE
Periodical
DOC. TYPE
Product Review
ABSTRACT
The article discusses the availability of the Gilenya, a prescription medicine indicated to treat relapsing forms of multiple sclerosis (MS) in adults, from Novartis AG and includes important safety information and its serious side effects.
ACCESSION #
91271869

 

Related Articles

  • Propylene glycol.  // Reactions Weekly;Sep2015, Vol. 1569 Issue 1, p181 

    The article presents a case study of a twenty nine year man who was being treated with high dosage of lorazepam drip having Propylene glycol, a chemical compound which act as a delivery content in order to remove alcohol while admitted in intensive care unit (ICU).

  • Grand Rapids: A City of Reinvention. Harms, Richard H.; Vescio, Portia // MAC Newsletter;Jan2012, Vol. 39 Issue 3, p1 

    The article offers travel tips to Grand Rapids, Michigan, and includes information on historic buildings, museums and the downtown called Heritage Hill.

  • Oral drug approved for relapsing multiple sclerosis. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;11/1/2010, Vol. 67 Issue 21, p1788 

    The article reports on the approval of Novartis AG's fingolimod, a podrug of sphingosine 1-phosphate receptor modulator, for treating patients with relapsing forms of multiple sclerosis by the U.S. Food & Drug Administration (FDA). It looks at how such drug aids in reducing the severity of...

  • FORMULATION AND EVALUATION OF HERBAL GEL CONTAINING PLUMERIA ALBA LEAVES EXTRACT. Shriwas, Shweta; Dwivedi, Sumeet; Dubey, Raghvendra // International Journal of Pharmacy & Life Sciences;Sep2016, Vol. 7 Issue 9, p9 

    The present research has been undertaken with the aim to formulate and evaluate the herbal gel containing Plumeria alba extract. The gel formulation was designed by using aqueous extract of Plumeria alba leaves in varied concentrations (2.5% and 5%) and evaluated using physiological...

  • FORMULATION AND EVALUATION OF ETHOSOMES OF PLUMERIA INDICA LINN. FLOWERS. Rajput, Ankita; Malviya, Jitendra; Prajapati, Sandeep; Shriwas, Shweta; Dwivedi, Sumeet; Dubey, Raghvendra // International Journal of Pharmacy & Life Sciences;Sep2016, Vol. 7 Issue 9, p14 

    The number of products based on new drug delivery systems has significantly increased in the past few years, and this growth is expected to continue in the near future. These biopharmaceuticals present challenges to drug delivery scientists because of their unique nature and difficulty in...

  • Toxic additives in medication for preterm infants. Whittaker, A.; Currie, A. E.; Turner, M. A.; Field, D. J.; Mulla, H.; Pandya, H. C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2009, Vol. 94 Issue 4, pF236 

    Background: Little is known about exposure of preterm infants to excipients during routine clinical care. Objective: To document excipient exposure in vulnerable preterm babies in a single centre, taking into account chronic lung disease (CLD) as a marker of illness severity. Design: Excipient...

  • Toxic additives in medication for preterm infants. Whittaker, A.; Currie, A. E.; Turner, M. A.; Field, D. J.; Mulla, H.; Pandya, H. C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2009, Vol. 94 Issue 4, pF236 

    Background: Little is known about exposure of preterm infants to excipients during routine clinical care. Objective: To document excipient exposure in vulnerable preterm babies in a single centre, taking into account chronic lung disease (CLD) as a marker of illness severity. Design: Excipient...

  • Drops decrease tear evaporation. McCulley, James P. // Ophthalmology Times;4/1/2011, Vol. 36 Issue 7, p30 

    The article focuses on the study of using artificial tears to treat dry eye in San Diego, California. It says that artificial tear products containing propylene glycol reduces evaporation of tears in patients with aqueous-deficient dry eye associated with meibomian gland dysfunction (MGD). Dr....

  • Toxic additives in medication for preterm infants. Whittaker, A.; Currie, A. E.; Turner, M. A.; Field, D. J.; Mulla, H.; Pandya, H. C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Apr2009, Vol. 94 Issue 4, pF236 

    Background: Little is known about exposure of preterm infants to excipients during routine clinical care. Objective: To document excipient exposure in vulnerable preterm babies in a single centre, taking into account chronic lung disease (CLD) as a marker of illness severity. Design: Excipient...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics